Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients.

Digenic inheritance Rimmed vacuolar myopathy SQSTM1 TIA1 Welander distal myopathy

Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 25 05 2023
revised: 28 09 2023
accepted: 26 10 2023
pubmed: 29 11 2023
medline: 29 11 2023
entrez: 28 11 2023
Statut: ppublish

Résumé

Welander distal myopathy typically manifests in late adulthood and is caused by the founder TIA1 c.1150G>A (p.Glu384Lys) variant in families of Swedish and Finnish descent. Recently, a similar phenotype has been attributed to the digenic inheritance of TIA1 c.1070A>G (p.Asn357Ser) and SQSTM1 c.1175C>T (p.Pro392Leu) variants. We describe two unrelated Spanish patients presenting with slowly progressive gait disturbance, distal-predominant weakness, and mildly elevated creatine kinase (CK) levels since their 6th decade. Electromyography revealed abnormal spontaneous activity and a myopathic pattern. Muscle magnetic resonance imaging (MRI) showed marked fatty replacement in distal leg muscles. A muscle biopsy, performed on one patient, revealed myopathic changes with rimmed vacuoles. Both patients carried the TIA1 p.Asn357Ser and SQSTM1 p.Pro392Leu variants. Digenic inheritance is supported by evidence from unrelated pedigrees and a plausible biological interaction between both proteins in protein quality control processes. Recent functional studies and additional case descriptions further support this. Clinical suspicion is necessary to seek both variants.

Identifiants

pubmed: 38016875
pii: S0960-8966(23)00761-7
doi: 10.1016/j.nmd.2023.10.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

983-987

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflict of interest to report.

Auteurs

Laura Bermejo-Guerrero (L)

Neuromuscular Disorders Unit, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Carlos Pablo de Fuenmayor Fernández-de la Hoz (CP)

Neuromuscular Disorders Unit, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Lidia González-Quereda (L)

Genetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; Genetics and Microbiology Department, Universitat Autonoma de Barcelona, Bellaterra, Spain.

Alba Segarra-Casas (A)

Genetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Genetics and Microbiology Department, Universitat Autonoma de Barcelona, Bellaterra, Spain.

Velina Nedkova (V)

Department of Neurology, Bellvitge Hospital, 08041 Barcelona, Spain.

Pia Gallano (P)

Genetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Paloma Martín-Jiménez (P)

Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Aurelio Hernández-Laín (A)

Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Montse Olivé (M)

Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; Neuromuscular Diseases Unit, Neurology Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Ana Arteche-López (A)

Department of Genetics, 12 de Octubre University Hospital, 28041 Madrid, Spain.

Cristina Domínguez-González (C)

Neuromuscular Disorders Unit, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; Mitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), Madrid, Spain. Electronic address: cdgonzalez@salud.madrid.org.

Classifications MeSH